Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
Applied DNA Sciences, Inc. (NASDAQ:APDN) has announced the release of its third quarter fiscal 2024 financial results on Thursday, August 8, 2024, after market close. The company will host a conference call for analysts and investors at 4:30 p.m. ET on the same day to discuss the financial results and recent accomplishments. Domestic callers can dial toll-free at 844-887-9402, while international callers can use 412-317-6798. A live webcast will be available, and a slide presentation will be embedded in the webcast. A telephonic replay of the conference call will be accessible until August 15, with replay access codes provided for different regions.
Applied DNA Sciences, Inc. (NASDAQ:APDN) ha annunciato il rilascio dei suoi risultati finanziari per il terzo trimestre dell'anno fiscale 2024 giovedì 8 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica per analisti e investitori alle 16:30 ET dello stesso giorno per discutere i risultati finanziari e i recenti successi. Chiamanti nazionali possono comporre il numero verde 844-887-9402, mentre chiamanti internazionali possono utilizzare il 412-317-6798. Sarà disponibile un webcast dal vivo e una presentazione in formato slide sarà integrata nel webcast. Un replay telefonico della conferenza sarà accessibile fino al 15 agosto, con codici di accesso al replay forniti per diverse regioni.
Applied DNA Sciences, Inc. (NASDAQ:APDN) ha anunciado la publicación de sus resultados financieros del tercer trimestre del año fiscal 2024 el jueves 8 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica para analistas e inversores a las 4:30 p.m. ET el mismo día para discutir los resultados financieros y los logros recientes. Llamantes nacionales pueden marcar el número gratuito 844-887-9402, mientras que llamantes internacionales pueden usar el 412-317-6798. Habrá un webcast en vivo y una presentación en diapositivas se incorporará al webcast. Un repetidor telefónico de la conferencia estará disponible hasta el 15 de agosto, con códigos de acceso para diferentes regiones.
Applied DNA Sciences, Inc. (NASDAQ:APDN)는 2024 회계연도 제3분기 재무결과를 2024년 8월 8일(목) 시장 종료 후 발표한다고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 애널리스트 및 투자자들과의 컨퍼런스 콜을 열어 재무 결과와 최근 성과에 대해 논의할 예정입니다. 국내 전화는 무료 번호 844-887-9402로 전화를 걸 수 있으며, 국제 전화는 412-317-6798을 사용할 수 있습니다. 실시간 웹캐스트가 제공되며, 슬라이드 프레젠테이션이 웹캐스트에 포함될 것입니다. 컨퍼런스 콜의 전화 재생은 8월 15일까지 이용 가능하며, 각 지역에 대한 재생 접근 코드가 제공됩니다.
Applied DNA Sciences, Inc. (NASDAQ:APDN) a annoncé la publication de ses résultats financiers du troisième trimestre de l'exercice 2024 le jeudi 8 août 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique pour les analystes et les investisseurs à 16h30 ET le même jour pour discuter des résultats financiers et des récentes réalisations. Les appelants nationaux peuvent composer le numéro gratuit 844-887-9402, tandis que les appelants internationaux peuvent utiliser le 412-317-6798. Un webinaire en direct sera disponible, et une présentation diaporama sera intégrée au webinaire. Un replay téléphonique de la conférence sera accessible jusqu'au 15 août, avec des codes d'accès pour différentes régions.
Applied DNA Sciences, Inc. (NASDAQ:APDN) hat die Veröffentlichung der Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2024 für Donnerstag, den 8. August 2024, nach Börsenschluss angekündigt. Das Unternehmen wird am gleichen Tag um 16:30 Uhr ET eine Telefonkonferenz für Analysten und Investoren abhalten, um die Finanzergebnisse und die jüngsten Erfolge zu besprechen. Inländische Anrufer können die gebührenfreie Nummer 844-887-9402 wählen, während internationale Anrufer die 412-317-6798 verwenden können. Es wird einen Live-Webcast geben, und eine Präsentation wird im Webcast eingebettet sein. Ein Telefon-Rückblick der Konferenz wird bis zum 15. August zugänglich sein, und Zugriffscodes für verschiedene Regionen werden bereitgestellt.
- None.
- None.
STONY BROOK, NY / ACCESSWIRE / August 7, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its third quarter fiscal 2024 financial results after market close on Thursday, August 8, 2024. In conjunction with this announcement, Applied DNA management will host a conference call for analysts and members of the investment community starting at 4:30 p.m. ET the same day. On this call, management will discuss the Company's financial results and recent accomplishments.
Date & Time: Thursday, August 8 @ 4:30 p.m. ET
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=WL2w2oZh
A telephonic replay of the conference call will be available until August 15 following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 9045385
Replay for international callers: 412-317-0088, replay access code 9045385
Replay for Canadian callers (toll free): 855-669-9658, replace access code 9045385
An accompanying slide presentation will be embedded in the webcast (live and replay) and can be accessed in the ‘Company Events' section under the ‘News & Events' tab of the Applied DNA investor relations website at https://investors.adnas.com/
The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, through our recent acquisition of Spindle Biotech, Inc. ("Spindle"), the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
X: @APDN
###
SOURCE: Applied DNA Sciences
View the original press release on accesswire.com
FAQ
When will Applied DNA Sciences (APDN) release its Q3 2024 financial results?
What time is Applied DNA's (APDN) Q3 2024 earnings call scheduled for?
How can investors access Applied DNA's (APDN) Q3 2024 earnings call?
Until what date will the replay of Applied DNA's (APDN) Q3 2024 earnings call be available?
